TomoTherapy to Announce First Quarter Financial Results on Tuesday, May 3, 2011
15 Abril 2011 - 1:30PM
Marketwired
TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced
radiation therapy solutions for cancer care, announced today that
it will release its 2011 first quarter financial results on
Tuesday, May 3, 2011 at 3:00 p.m. CDT.
TomoTherapy will hold an investment community conference call on
Tuesday, May 3, 2011 beginning at 4:00 p.m. CDT. Fred Robertson,
M.D., CEO, and Thomas Powell, CFO, will review first quarter
performance. To join the conference call, dial 1-866-804-6927
(international 1-857-350-1673) and enter passcode 65695506. A
replay of the conference call will be available at 7:00 p.m. CDT on
May 3, 2011, through 10:59 p.m. CDT on May 10, 2011. To access the
replay, dial 1-888-286-8010 (international 1-617-801-6888) and
enter passcode 98537692.
For individual investors, a live Webcast of the conference call
will be available on the Investor Relations page of
TomoTherapy.com. Institutional investors can access the Webcast
through a password-protected site, www.streetevents.com. An
archived Webcast of TomoTherapy's conference call will be available
for two weeks.
About TomoTherapy Incorporated TomoTherapy
Incorporated develops, markets and sells advanced radiation therapy
solutions that can be used to treat a wide variety of cancers, from
the most common to the most complex. The ring gantry-based
TomoTherapy® platform combines integrated CT imaging with conformal
radiation therapy to deliver sophisticated radiation treatments
with speed and precision while reducing radiation exposure to
surrounding healthy tissue. TomoTherapy's suite of solutions
include its Hi-Art® treatment system, which has been used to
deliver more than three million CT-guided, helical
intensity-modulated radiation therapy (IMRT) treatment fractions;
the TomoHD™ treatment system, designed to enable cancer centers to
treat a broader patient population with a single device; and the
TomoMobile™ relocatable radiation therapy solution, designed to
improve access and availability of state-of-the-art cancer care.
TomoTherapy's stock is traded on the NASDAQ Global Select Market
under the symbol TOMO. To learn more about TomoTherapy, please
visit TomoTherapy.com.
©2011 TomoTherapy Incorporated. All rights reserved.
TomoTherapy, Tomo, TomoDirect, TQA, the TomoTherapy logo and Hi-Art
are among trademarks, service marks or registered trademarks of
TomoTherapy Incorporated in the United States and other
countries.
Investor Contact: Thomas E. Powell Chief Financial
Officer 608.824.2800 Email Contact Media Contacts: Kevin
O'Malley Director, Corporate Communications 608.824.3384 Email
Contact Susan Lehman Rockpoint Public Relations 510.832.6006 Email
Contact
Tom Online (NASDAQ:TOMO)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Tom Online (NASDAQ:TOMO)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024